Chronic daily headache

Practical Neurology

Volumn 7, Issue 4, 2007, Pages 212-221

  Weatherall, Mark W ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHLORPROMAZINE; CLONIDINE; DOSULEPIN; FLUNARIZINE; GABAPENTIN; IBUPROFEN; LISINOPRIL; MAGNESIUM CITRATE; METHYSERGIDE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NADOLOL; NAPROXEN; NORTRIPTYLINE; PIZOTIFEN; PREDNISOLONE; PROPRANOLOL; RIBOFLAVIN; SEROTONIN ANTAGONIST; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UBIDECARENONE; UNINDEXED DRUG; VALPROIC ACID;

ATAXIA; CHRONIC DAILY HEADACHE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COLD LIMB; COMORBIDITY; DEPRESSION; DETOXIFICATION; DISEASE CLASSIFICATION; DISEASE COURSE; DROWSINESS; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRY EYE; EXTRAPYRAMIDAL SYNDROME; FATIGUE; FIBROSIS; HUMAN; JOB STRESS; LEG PAIN; LIBIDO DISORDER; NEPHROLITHIASIS; NEW DAILY PERSISTENT HEADACHE; NIGHTMARE; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PSYCHOSIS; RAYNAUD PHENOMENON; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; TRANSFORMED MIGRAINE; TREATMENT DURATION; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ANALGESICS; ANTI-ANXIETY AGENTS; HEADACHE DISORDERS; HUMANS; MENTAL DISORDERS; STEROIDS; SUBSTANCE WITHDRAWAL SYNDROME; WITHHOLDING TREATMENT;

EID: 34547612531     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2007.124511     Document Type: Review

References (17)

1. Stovner U, Hagen J, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210.
2. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalagia 2006; 26:742-6.
3. Sancisi E, Cevoli S, Pierangeli G, et al. Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache. Neurol Sci 2007;28:2-8.
4. Bahra A, Walsh M, Menon S, et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43:179-90.
5. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic overuse headache evolving from episodic migraine. Brain 2006;129:543-50.
6. Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication, overuse headache reported in a tertiary care headache centre over a 15-year period. Headache 2006; 46:766-72.
7. Zeeberg P, Olesen J, Jensen R. Probable medication overuse headache: the effect of a two-month withdrawal period. Neurology 2006; 66:1894-88.
8. Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomised, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006; 26:1097-105.
9. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Second edition. Cephalalgia 2004;24(Suppl 1):1-160.
10. Saper JR, Hamel RL, Lake AE. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005;25:545-6.
11. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-overuse headache. Cephalalgia 2000;20:107-13.
12. Afridi SK, Shields KS, Bhola R, et al. Greater occipital nerve injection in primary headache syndromes-prolonged effects from a single injection. Pain 2006;122:126-9.
13. Katsarava Z, Muessig M, Dzagnidze A, et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005;25:12-15.
14. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26:1192-8.
15. Penzien DB, et al. Complex co-morbidities of recurrent headache disorders. Headache 2006;46:1324-423.
16. Lipton RB, Silberstein SD, Saper JR, et al. Why headache treatment fails. Neurology 2003;60:1064-70.
17. Goadsby PJ, Schoenen J, Ferrari MD, et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006;26:1168-70.